TipRanks
Go Ultimate55% OFF

Astellas Pharma (4503N) Q4 2022 Earnings Report

MX:4503N Q4 2022 EPS Results

Actual EPS
-MXN 2.96
Consensus EPS
-MXN 2.45
Beat/Miss
Missed by -MXN 0.51
One Year Ago EPS
MXN 1.88

MX:4503N Q4 2022 Revenue Results

Actual Revenue
MXN 41.68B
Expected Revenue
MXN 42.52B
Beat/Miss
Missed by -MXN 838.03M
YoY Revenue Growth
+16.58%

Earnings Announcement Details

Quarter
Q4 2022
Date
04/27/2023
Time
Before Open
Conference Call
Thursday, April 27, 2023

Q4 2022 Earnings Call Audio

MX:4503N Q4 2022 Earnings Call
0:00 / 0:00

Q4 2022 Earnings Slide Deck

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:4503N Earnings History

MX:4503N earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 04, 20262026 (Q2)7.65-5.2―
Aug 05, 20262026 (Q1)6.379.314.5107.09% (+4.82)
Apr 27, 20262025 (Q4)3.602.864.92-41.95% (-2.06)
Feb 04, 20262025 (Q3)5.406.59-6.42202.73% (+13.01)
Oct 30, 20252025 (Q2)3.515.202.36120.44% (+2.84)
Jul 30, 20252025 (Q1)2.344.502.4782.00% (+2.03)
Apr 25, 20252024 (Q4)2.514.92-2.18325.50% (+7.11)
Feb 04, 20252024 (Q3)2.89-6.421.22-624.52% (-7.64)
Oct 30, 20242024 (Q2)2.122.36-0.092607.50% (+2.45)
Aug 01, 20242024 (Q1)1.122.472.1713.76% (+0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed